Keyphrases
Acetamide
53%
Peptide-based Inhibitors
53%
Mitogen-activated Protein Kinase Kinase 7 (MKK7)
53%
ERK2
53%
Covalent Ligand
53%
Electrophile
53%
Ligand-directed
53%
Docking Site
53%
High-throughput
53%
Self-immolative
53%
Cancer Evolution
53%
Extrachromosomal DNA
53%
DNA Amplification
53%
Covalent Inhibitor
39%
Chloroacetamide
32%
Scale Levels
17%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
17%
Inhibitory Activity
17%
Biochemical Methods
17%
Biological Assay
17%
D-recruitment Site
17%
Covalent Kinase Inhibitor
17%
ATP Binding Site
17%
Cycloaddition
17%
Biological Methods
17%
Western Blot
17%
Copper-catalyzed
17%
ELK1
17%
Site-directed Spin Labeling
10%
Mouse Model
10%
Kinase Assay
10%
In Vivo Applications
10%
Ibrutinib
10%
FDA-approved Drugs
10%
Acrylamide
10%
Traceless
10%
Pin1 Inhibitor
10%
Low Reactivity
10%
Protein Labeling
10%
Competing Interests
9%
DNA Degradation
9%
Selective Pressure
9%
Micronucleus
9%
Small Molecules
8%
Kinase Inhibition
8%
Binding Protein
8%
SAP2
8%
Peptide-based Kinase Inhibitor
8%
Cell Viability
8%
Colorectal Cancer Cells
8%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Phosphotransferase Inhibitor
62%
Bioassay
53%
Electrophile
53%
Acetamide Derivative
53%
Mitogen Activated Protein Kinase 1
53%
Western Blot
53%
Chloroacetamide
32%
Binding Site
26%
Adenosine Triphosphate
26%
Buffer
10%
Acetamide
10%
Ibrutinib
10%
Mouse Model
10%
Cell Viability
8%
Disease
8%
Anticarcinogen
8%
Binding Protein
8%
Malignant Neoplasm
8%
Colon Carcinoma
8%
Biochemistry, Genetics and Molecular Biology
Kinase
53%
Phosphotransferase
53%
Gene Amplification
53%
Cancer Cell
37%
Adenosine Triphosphate
32%
Binding Site
32%
Cycloaddition
26%
Centromere
26%
Daughter Cell
26%
DNA Degradation
26%
Genome Evolution
26%
Autophagy
26%
ELK1
21%
Protein-Protein Interaction
10%
Colon
10%
Cell Viability
10%
Small Molecule
10%
Binding Protein
10%
